Tag: Anaphylactic Shock
Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
Most recipients with anaphylaxis had allergy histories, with 31 percent having prior anaphylaxis
1998 to 2018 Saw Jump in Admissions for Food-Induced Anaphylaxis
U.K. data revealed decrease in case fatality rate during study period; cow's milk responsible for 26 percent of deaths in school-aged children
Prevalence of Peanut Allergy 2.9 Percent Among U.S. Adults
More than 17 percent of adults with peanut allergy reported onset in adulthood; about one in five had ED visits in past year
2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots
Nine of the 10 cases occurred in individuals with documented history of allergies, allergic reactions
Allergists Affirm Safety of COVID-19 Vaccines for Most
All patients should be observed for 15 minutes after vaccination; staff should be trained in anaphylaxis management
11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
Median interval from vaccine receipt to symptom onset was 13 minutes
ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies
Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol